Clinical Trial Update: First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study of OVM-200, a therapeutic cancer vaccine, being tested in prostate cancer, non-small cell lung cancer, and ovarian cancer; currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Ovarian Cancer
• Prostate Cancer

Drugs mentioned

• OVM-200

Snippet

Sponsor: Oxford Vacmedix UK Ltd. | Conditions: Prostate Cancer, Non Small Cell Lung Cancer | Phase 1 | Status: RECRUITING